Previous 10 | Next 10 |
home / stock / biovf / biovf news
STOCKHOLM , June 12, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has signed an agreement to acquire, from Novimmune's shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D ca...
STOCKHOLM , April 30, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Amy Pott as the new Head of Sobi North America . She takes over effective today, replacing Rami Levin who is leaving Sobi. " Sobi North America is entering a new phase in l...
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2019 Earnings Conference Call April 25, 2019 4:00 AM ET Company Participants Guido Oelkers – Chief Executive Officer Henrik Stenqvist – Chief Finanical Officer Milan Zdravkovic – Chief Scientific Officer Confer...
The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2019 Q1 earnings Read more ...
Swedish Orphan Biovitrum AB (publ) ( OTCPK:BIOVF ): Q1 Non-GAAP EPS of SEK3.03; GAAP EPS of SEK3.14. More news on: Swedish Orphan Biovitrum AB (publ), Earnings news and commentary, Healthcare stocks news, Read more ...
STOCKHOLM , April 18, 2019 /PRNewswire/ - Swedish Orphan Biovitrum AB (publ) (Sobi™) has released the company's 2018 Annual and Sustainability Report. The integrated report summarises our business and strategy, financial performance and work on sustainability. "2018 was a year ...
STOCKHOLM , March 25, 2019 /PRNewswire/ -- Sobi™ and Novimmune SA have both been selected as honourees by the National Organization for Rare Disorders (NORD) for the 2019 Rare Impact Awards. The companies were nominated in the category of Industry Innovation in recognition of the U...
STOCKHOLM , Feb. 21, 2019 /PRNewswire/ -- Save the date for Swedish Orphan Biovitrum AB (publ) (Sobi™) Capital Markets Day on 14 May 2019 . The event will take place at Karolinska Institutet Biomedicum, Solnavägen 9, Solna, from 12:30 – 16:30. A lighter lunch will be...
The following slide deck was published by Swedish Orphan Biovitrum AB in conjunction with their 2018 Q4 earnings Read more ...
Swedish Orphan Biovitrum AB ( OTCPK:BIOVF ): Q4 GAAP EPS of SEK2.20. More news on: Swedish Orphan Biovitrum AB, Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...